Direct visualization of Bcl-2 family protein interactions using live cell fluorescent protein redistribution assays

被引:0
|
作者
C Wong
D J Anderson
E F Lee
W D Fairlie
M J C Ludlam
机构
[1] Genentech,Department of Research Oncology
[2] Inc.,Department of Medical Biology
[3] The Walter and Eliza Hall Institute of Medical Research,undefined
[4] The University of Melbourne,undefined
来源
Cell Death & Disease | 2012年 / 3卷
关键词
apoptosis; Bcl-2 family; cancer; microscopy; drug screening;
D O I
暂无
中图分类号
学科分类号
摘要
Bcl-2 family proteins have important roles in tumor initiation, progression and resistance to therapy. Pro-survival Bcl-2 proteins are regulated by their interactions with pro-death BH3-only proteins making these protein–protein interactions attractive therapeutic targets. Although these interactions have been extensively characterized biochemically, there is a paucity of tools to assess these interactions in cells. Here, we address this limitation by developing quantitative, high throughput microscopy assays to characterize Bcl-2 and BH3-only protein interactions in live cells. We use fluorescent proteins to label the interacting proteins of interest, enabling visualization and quantification of their mitochondria-localized interactions. Using tool compounds, we demonstrate the suitability of our assays to characterize the cellular activity of putative therapeutic molecules that target the interaction between pro-survival Bcl-2 and pro-death BH3-only proteins. In addition to the relevance of our assays for drug discovery, we anticipate that our work will contribute to an improved understanding of the mechanisms that regulate these important protein–protein interactions within the cell.
引用
收藏
页码:e288 / e288
相关论文
共 50 条
  • [1] Direct visualization of Bcl-2 family protein interactions using live cell fluorescent protein redistribution assays
    Wong, C.
    Anderson, D. J.
    Lee, E. F.
    Fairlie, W. D.
    Ludlam, M. J. C.
    CELL DEATH & DISEASE, 2012, 3 : e288 - e288
  • [2] Visualization of Bcl-2 family protein interactions enables screening and characterization of Bcl-2 family small molecule inhibitors in live cells.
    Anderson, D.
    Wong, C.
    Lee, E.
    Fairlie, W.
    Ludlam, M.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [3] The Bcl-2 protein family
    Antonsson, B
    Martinou, JC
    EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 50 - 57
  • [4] Bcl-2 family proteins as a paradigm for protein: protein interactions as chemotherapy targets
    Andrews, David W.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [6] Analysis of Bcl-2 family members and protein-protein interactions using novel multiplex immunoassays
    Maheshwari, Reeti
    Schluter, Melissa
    Pepin, Danielle
    Hwang, Joseph
    CANCER RESEARCH, 2017, 77
  • [7] Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells
    Osterlund, Elizabeth J.
    Hirmiz, Nehad
    Pemberton, James M.
    Nougarede, Adrien
    Liu, Qian
    Leber, Brian
    Fang, Qiyin
    Andrews, David W.
    SCIENCE ADVANCES, 2022, 8 (16):
  • [8] BCL-2 FAMILY PROTEIN INHIBITORS
    Krivoshik, A. P.
    ANNALS OF ONCOLOGY, 2010, 21 : 25 - 25
  • [9] A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
    Llambi, Fabien
    Moldoveanu, Tudor
    Tait, Stephen W. G.
    Bouchier-Hayes, Lisa
    Temirov, Jamshid
    McCormick, Laura L.
    Dillon, Christopher P.
    Green, Douglas R.
    MOLECULAR CELL, 2011, 44 (04) : 517 - 531
  • [10] Cell death regulation by the Bcl-2 protein family in the mitochondria
    Tsujimoto, Y
    JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (02) : 158 - 167